FDA NDC Directory · JSON-LD · Markdown
NDC 16571-737 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE
| Labeler / Manufacturer | Rising Pharma Holdings, Inc. |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA205956 |
| Dosage form / route | CAPSULE, EXTENDED RELEASE · ORAL |
| Active ingredients | PROPAFENONE HYDROCHLORIDE (325 mg/1) |
| Marketing started | 20201216 |
| Package count | 2 |
Source: openFDA. Public-domain (CC0).